Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

作者: J.V. Gannon , R. Greaves , R. Iggo , D.P. Lane

DOI: 10.1002/J.1460-2075.1990.TB08279.X

关键词:

摘要: Point mutations in the p53 gene are most frequently identified genetic change human cancer. They convert murine from a tumour suppressor into dominant transforming oncogene able to immortalize primary cells and bring about full transformation combination with an activated ras gene. In both systems lie regions of conserved man Xenopus. We have developed monoclonal antibody designated PAb240 which does not immunoprecipitate wild type p53. A series different mutants all react more strongly than PAb246. The reactive form cannot bind SV40 large T antigen but HSP70. contrast, PAb246 binds recognizes forms when they denatured. It reacts mammalian chicken immunoblots. propose that immunoprecipitation by is diagnostic mutation suggest point recessive exert common conformational effect on protein. This abolishes binding promotes self-oligomerization. These results consistent negative model where mutant protein neutralizes activity conformation.

参考文章(34)
C A Finlay, P W Hinds, T H Tan, D Eliyahu, M Oren, A J Levine, Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Molecular and Cellular Biology. ,vol. 8, pp. 531- 539 ,(1988) , 10.1128/MCB.8.2.531
P W Hinds, C A Finlay, A B Frey, A J Levine, Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Molecular and Cellular Biology. ,vol. 7, pp. 2863- 2869 ,(1987) , 10.1128/MCB.7.8.2863
W J Welch, J R Feramisco, Rapid purification of mammalian 70,000-dalton stress proteins: affinity of the proteins for nucleotides. Molecular and Cellular Biology. ,vol. 5, pp. 1229- 1237 ,(1985) , 10.1128/MCB.5.6.1229
J. R. Jenkins, K. Rudge, G. A. Currie, Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature. ,vol. 312, pp. 651- 654 ,(1984) , 10.1038/312651A0
Antony W. Braithwaite, Horst-Werner Sturzbecher, Christine Addison, Colin Palmer, Karran Rudge, John R. Jenkins, Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature. ,vol. 329, pp. 458- 460 ,(1987) , 10.1038/329458A0
V. Simanis, D.P. Lane, An immunoaffinity purification procedure for SV40 large T antigen. Virology. ,vol. 144, pp. 88- 100 ,(1985) , 10.1016/0042-6822(85)90308-3
D. Eliyahu, D. Michalovitz, S. Eliyahu, O. Pinhasi-Kimhi, M. Oren, Wild-type p53 can inhibit oncogene-mediated focus formation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 8763- 8767 ,(1989) , 10.1073/PNAS.86.22.8763
Daniel Eliyahu, Avraham Raz, Peter Gruss, David Givol, Moshe Oren, Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. ,vol. 312, pp. 646- 649 ,(1984) , 10.1038/312646A0
T Takahashi, M. Nau, I Chiba, M. Birrer, R. Rosenberg, M Vinocour, M Levitt, H Pass, A. Gazdar, J. Minna, p53: a frequent target for genetic abnormalities in lung cancer Science. ,vol. 246, pp. 491- 494 ,(1989) , 10.1126/SCIENCE.2554494